The authors respond to “Opioid agonist dosage adequacy from clinical and patient perspectives: further considerations”

Documenti analoghi

• Opioid agonist dosage adequacy from clinical and patient perspectives: further considerations
  di: Trujols, Joan, et al.
  Pubblicazione: (2019)
• Opioid agonist treatment dosage and patient-perceived dosage adequacy, and risk of hepatitis C infection among people who inject drugs
  di: Artenie, Andreea A., et al.
  Pubblicazione: (2019)
• The authors respond to “The 2017 Canadian opioid guideline: already time for an overhaul”
  di: Busse, Jason W., et al.
  Pubblicazione: (2018)
• Global opioid agonist treatment: A review of clinical practices by country
  di: Jin, Harry, et al.
  Pubblicazione: (2020)
• The authors respond to “Inconsistencies in the 2017 Canadian Guideline for Opioids for Chronic Noncancer Pain”
  di: Busse, Jason W., et al.
  Pubblicazione: (2017)